Company Monitoring Page for ASCO

latest headlines for company on cafepharma

Cancer Immunotherapy the Top Focus at ASCO
CNBC
Fri, 05/31/13 - 12:31 pm
Tags:
ASCO, immunotherapy, cancer, Bristol-Myers Squibb, Roche, and Merck
ASCO presentations portend future shock of immunotherapy drug prices
Fierce Biotech
Thu, 05/30/13 - 11:37 am
Tags:
ASCO, drug pricing, immunotherapy, Merck, Bristol-Myers Squibb
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
Tags:
cancer, ASCO, nivolumab, Bristol-Myers Squibb, idelalisad, Gilead, PEGPH20, Halozyme, pancreatic cancer
ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine
TheStreet.com
Thu, 05/16/13 - 10:38 am
Tags:
ASCO, lung cancer, vaccines, Oncothyreon, Stimuvax, Merck KGaA
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thu, 05/16/13 - 08:54 am
Tags:
Gilead, ASCO, JNJ, Pharmacyclics, idelalisab, ibrutinib, CLL
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
Tags:
ASCO, Arqule, Array Biopharma, Astex, AstraZeneca, Bristol-Myers Squibb, GSK, Curis, Exelixis, Pfizer, Immunogen, Seattle Genetics, Sanofi, Synta
Cancer Drug Targets: The March of the Lemmings
Forbes
Thu, 06/7/12 - 04:58 pm
Tags:
cancer, ASCO
ASCO Data Suggest Dendreon's Provenge Should Go First
Seeking Alpha
Thu, 06/7/12 - 03:27 pm
Tags:
Provenge, prostate cancer, Dendreon, ASCO, JNJ
Study of Treanda shows great promise for Teva's drug
Fierce Pharma
Mon, 06/4/12 - 05:46 pm
Tags:
Teva Pharmaceuticals, Treanda, ASCO, non-Hodgkin's lymphoma
ASCO '12: Ariad Pharma Leukemia Drug Posts Improved Response Rates
TheStreet.com
Mon, 06/4/12 - 10:58 am
Tags:
ASCO, Ariad Pharma, leukemia, Ponatinib
Johnson & Johnson, Bristol-Myers' Cancer Drugs Grab Spotlight
Minyanville
Mon, 06/4/12 - 10:54 am
Tags:
JNJ, Bristol-Myers Squibb, ASCO, Zytiga, anti-PD-1 immunotherapy
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
Tags:
ASCO, antibody-drug conjugate, Roche, Genentech, Immunogen, T-DM1, Adcetris, Seattle Genetics
ASCO Stocks To Consider This Week
Seeking Alpha
Tue, 05/29/12 - 11:15 am
Tags:
ASCO, Arena Pharmaceuticals, Vivus, JNJ, Bayer, Onyx, Pharmacyclics
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
Tags:
ASCO, Synta, Sunesis, Arqule, Cyclacel, Aveo, Bristol-Myers Squibb
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Seeking Alpha
Thu, 05/24/12 - 12:53 pm
Tags:
ASCO, Eli Lilly, Galena Biopharma, Dendreon, Exelixis, CytRx, Array Biopharma, Ariad Pharmaceuticals
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thu, 05/17/12 - 10:35 am
Tags:
ASCO, Array Biopharma, Exelixis, Pharmacyclics, Onyx, Seattle Genetics, Aveo, Ariad Pharmaceuticals, Arqule, Oncothyreon
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
Tags:
ASCO, Genentech, T-DM1, breast cancer, tivozanib, Aveo, kidney cancer, Onyx, Bayer, regorafenib, colorectal cancer, Adcetris, Seattle Genetics, JNJ, prostate cancer, Zytiga, cabozantinib, Exelixis, Enzalutamide, Medivation, Ponatinib, chronic myeloid leukemia, Ariad Pharmaceuticals
Pfizer, Johnson & Johnson, Ariad, and Medivation in Spotlight at Cancer Meeting
Minyanville
Wed, 05/16/12 - 10:53 am
Tags:
ASCO, Pfizer, JNJ, Ariad Pharmaceuticals, Medivation
Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade
Seeking Alpha
Tue, 05/15/12 - 12:12 pm
Tags:
ASCO, Allos, Ariad Pharmaceuticals, Arena Pharmaceuticals, Repligen, Sunesis
An ASCO Bio-Pharma Catalyst Trade With A Promising Leukemia Drug
Seeking Alpha
Wed, 05/9/12 - 10:19 am
Tags:
leukemia, ASCO, Sunesis, Bristol-Myers Squibb, vosaroxin, Ariad Pharmaceuticals, Sanofi, AML, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.